Suxia Luo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Glycosylation and Glycoproteins Research
- RNA Research and Splicing
- Natural product bioactivities and synthesis
Papers in
-
- Circular RNAs in diseases 3
-
- Gastric Cancer Management and Outcomes 5
- Metastasis and carcinoma case studies 2
- Co-authors
- Xiaoli Liu (1 shared paper)Huaimin Liu (1 shared paper)Qingfeng Jiang (1 shared paper)Zhenzhen Liu (2 shared papers)Jia Li (1 shared paper)Haiying Ma (1 shared paper)Xianfu Sun (1 shared paper)Miaomiao Sun (1 shared paper)
In The Last Decade
Suxia Luo
25 papers receiving 519 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 213
- Molecular Biology 300
- Biochemistry 16
- Oncology 64
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Suxia Luo
This map shows the geographic impact of Suxia Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Luo more than expected).
Fields of papers citing papers by Suxia Luo
This network shows the impact of papers produced by Suxia Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Luo. The network helps show where Suxia Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Suxia Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 108 | |
| 2 | 2013 | 98 | |
| 3 | 2019 | 68 | |
| 4 | MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. | 2015 | 48 |
| 5 | 2017 | 39 | |
| 6 | 2019 | 30 | |
| 7 | 2020 | 18 | |
| 8 | 2021 | 17 | |
| 9 | 2009 | 16 | |
| 10 | 2015 | 16 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 6 | |
| 15 | 2024 | 4 | |
| 16 | 2021 | 4 | |
| 17 | [The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402]. | 2008 | 3 |
| 18 | 2024 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2020 | 2 |
About Suxia Luo
Suxia Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Oncology, having authored 26 papers that have together received 522 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), Cancer Treatment and Pharmacology (2 papers), Esophageal Cancer Research and Treatment (2 papers), Metastasis and carcinoma case studies (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Cancer Research (213 citations), Molecular Biology (300 citations), Biochemistry (16 citations), Oncology (64 citations) and Pulmonary and Respiratory Medicine (54 citations). Suxia Luo has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Xiaoli Liu, Huaimin Liu, Qingfeng Jiang, Zhenzhen Liu, Jia Li, Haiying Ma, Xianfu Sun, Miaomiao Sun, Beibei Chen and Yu Mu. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications, Signal Transduction and Targeted Therapy, Cellular & Molecular Biology Letters and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.